Jpmorgan Chase & CO Quotient LTD Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$0.16 - $0.31 $156,157 - $302,554	-975,983 Reduced 27.96%	2,515,171 $377,000
Q2 2022 Aug 11, 2022	BUY	$0.24 - $1.2 $828,825 - $4.14 Million	3,453,439 Added 9156.67%	3,491,154 $838,000
Q1 2022 May 11, 2022	SELL	$0.94 - $2.38 $45,134 - $114,275	-48,015 Reduced 56.01%	37,715 $45,000
Q4 2021 Feb 10, 2022	BUY	$1.89 - $3.12 $62,713 - $103,527	33,182 Added 63.15%	85,730 $222,000
Q3 2021 Nov 12, 2021	BUY	$2.34 - $3.77 $122,962 - $198,105	52,548 New	52,548 $123,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.